Questions and answers

Ovarian cyst or ovarian cancer: how can you tell?

The difference between a simple cyst and a suspicious one, what O-RADS means on an ultrasound report, the role of CA-125, and when watching is enough and when surgery is needed

Updated: 28 October 20267 min read10 references
Show content for:
Short answer

A cancerous ovarian cyst usually has no typical symptom: most cysts and lumps of the ovary are found by chance during an examination or an ultrasound scan, not because of symptoms [1]. The symptoms to take seriously are those of ovarian cancer: pain in the pelvis or abdomen, bloating or a growing abdomen, feeling full quickly and needing to pass urine often, when they are new and happen on more than 12 days a month [10]. Fortunately, most ovarian cysts are benign [1]; what decides the risk is how the cyst looks on ultrasound, which is written on the ultrasound report as an O-RADS score [6, 8].

Key points

  • Most ovarian cysts and lumps are benign and are often found by chance on an ultrasound scan [1].
  • Functional cysts are common during the reproductive years, and most go away on their own within a few menstrual cycles [2].
  • A simple cyst (fluid only, with a smooth wall) has a very low risk of cancer; in a study of nearly 3000 women aged 50 or over with simple cysts, none of these cysts became cancer [3].
  • The appearance of the cyst on ultrasound is the most important clue: an irregular solid part, many small growths inside the cyst, a lot of blood flow and fluid in the abdomen make cancer more likely [5].
  • On an ultrasound report, O-RADS 2 means almost certainly benign; O-RADS 4 and 5 mean that further tests and advice from a gynaecological cancer surgeon are needed [6, 7].
  • The CA-125 blood test cannot show on its own whether a cyst is cancerous; the appearance of the cyst on ultrasound matters more [8].

Is an ovarian cyst cancer? Types of ovarian cysts and lumps

A cyst is a sac filled with fluid. An ovarian cyst is usually not cancer: most cysts and lumps of the ovary are benign [1]. A follicle (a small sac in which an egg grows) or a corpus luteum up to 3 cm is part of a normal ovary [7]. Sometimes these structures grow larger and are then called "functional cysts"; they are very common during the reproductive years [2].

Types of ovarian cysts and lumps
TypeWhat it meansWhat usually happens
Functional cystA cyst that forms during the normal cycle of ovulationMost go away on their own within a few menstrual cycles [2]
Haemorrhagic cyst, endometrioma ("chocolate cyst") and dermoid cystBenign types whose appearance on ultrasound is well knownIf they look typical, they are almost certainly benign [6]; a cyst that stays after a few menstrual cycles is often a non-functional type such as an endometrioma [2]
Borderline tumourAbnormal cells that may become cancer, but usually do not [9]It is removed with surgery, sometimes keeping the other ovary; the outlook is good, especially when it is found early [9]
Ovarian cancerA malignant tumourSurgery and usually chemotherapy; see further down the page

The type of cyst is judged from how it looks on ultrasound, and sometimes it is only confirmed after surgery, when the tissue is examined.

Ovarian cancer symptoms vs ovarian cyst symptoms: is there a difference?

No single symptom shows that a cyst is cancerous. Most cysts and lumps of the ovary are found by chance during an examination or an ultrasound scan, not because of symptoms [1].

  • Benign cysts sometimes cause sudden or on-and-off pain [1], for example when the cyst twists or bursts. These complications are uncommon: in a large study of women whose benign-looking lumps were only monitored, fewer than 1 in 100 had a twisted or burst cyst within 2 years [4].
  • The symptoms of ovarian cancer are usually vague: pain in the pelvis or abdomen, bloating or a growing abdomen, feeling full quickly or difficulty eating, and needing to pass urine often or urgently. When these symptoms are new (less than a year) and happen on more than 12 days a month, they are worth checking [10].

So if you have a cyst and symptoms like these, tell your doctor; but the main decision is based on how the cyst looks on ultrasound. Read more: What are the symptoms of ovarian cancer?

Can an ovarian cyst turn into cancer?

A cyst that looks benign on ultrasound rarely becomes cancer:

  • In a study in the United States of women aged 50 or over, nearly 3000 women had a simple cyst smaller than 10 cm. None of these cysts turned into cancer, and about 7 in 10 of the cysts went away on their own [3].
  • In an international study of women with benign-looking lumps who were monitored instead of having surgery, about 4 in 1000 had cancer within 2 years, and in about 1 in 5 the lump went away on its own [4].

But if the appearance of a cyst changes during follow-up (for example, it develops an inner wall or a solid part), it needs to be checked again. In the same American study, the women who had earlier had a simple cyst and later developed cancer had either first developed a new change in the ovary, had their cyst disappear, or had cancer in the other ovary [3]. A cyst that does not go away after 2 to 3 menstrual cycles is usually not functional and often needs surgery [2].

The ultrasound report: O-RADS and worrying signs

Many radiologists write a score called O-RADS on the ultrasound report, from 0 to 5; each score shows the chance of cancer and the next step [6, 7].

What does the O-RADS score on an ovarian ultrasound mean? [6, 7]
ScoreWhat it meansChance of cancerUsual next step
O-RADS 0The assessment is incompleteNot knownRepeat ultrasound or another test
O-RADS 1Normal ovary (a follicle or corpus luteum up to 3 cm)NormalNothing needed
O-RADS 2Almost certainly benign, such as a simple cystFewer than 1 in 100Depending on size and age: no follow-up or a repeat ultrasound
O-RADS 3Low risk1 to fewer than 10 in 100If it is not removed, repeat ultrasound; sometimes MRI; under the care of a gynaecologist
O-RADS 4Intermediate risk10 to fewer than 50 in 100Specialist ultrasound or MRI; a gynaecologist with advice from a gynaecological cancer surgeon
O-RADS 5High risk50 or more in 100Referral to a gynaecological cancer surgeon

The details of follow-up depend on the size of the cyst and whether you have been through the menopause. The O-RADS score is interpreted together with age, symptoms and examination.

Signs seen more often in benign lumps [5]: a unilocular cyst (a single fluid-filled space); a very small solid part (less than 7 mm); an "acoustic shadow" behind the lump; a cyst with several spaces and smooth walls smaller than 10 cm; and no blood flow on Doppler ultrasound.

Signs that make cancer more likely [5]: a solid lump with an irregular shape; free fluid in the abdomen (ascites); at least 4 small growths on the inner wall of the cyst; an irregular lump with several spaces and solid parts measuring 10 cm or more; and a lot of blood flow on Doppler.

With these simple rules, about 3 in 4 lumps can be classified, and most of them are classified correctly [5]. An experienced ultrasound specialist gives the most accurate assessment; when one is not available, these models help. If the ultrasound is not conclusive, MRI is the next step [8].

What role do CA-125 and age play?

The CA-125 blood test is the best blood test to help assess an ovarian lump before surgery, but it is not useful for screening for ovarian cancer [8]. The appearance of the lump on ultrasound matters more than CA-125, and adding CA-125 to ultrasound models does not make them more accurate [8]. When the doctor suspects cancer, CA-125 helps [8]. Read more: I have an ovarian cyst; do I need a tumour marker test?

Age and family history also matter and affect decisions about an ovarian lump [1]. The "risk of malignancy index" (RMI) combines menopausal status, the appearance of the lump on ultrasound and CA-125; but newer ultrasound models are more accurate [8]. If ovarian or breast cancer runs in your family, tell your doctor. Read: Is cancer hereditary?

When is a cyst just monitored, and when is surgery needed?

  1. 1

    A simple cyst or functional cyst

    Usually waiting and a repeat ultrasound after 2 to 3 menstrual cycles is enough [2]. In studies, the contraceptive pill did not make functional cysts go away faster [2].

  2. 2

    A lump that looks benign

    Regular ultrasound follow-up instead of surgery is a safe choice; in women monitored this way, the risk of cancer and of complications such as twisting was low [4]. If the cyst is large or painful, or does not go away over time, surgery may be needed [2].

  3. 3

    A suspicious lump (O-RADS 4 or 5)

    Further assessment with specialist ultrasound or MRI, and a decision about surgery together with a gynaecological cancer surgeon [6, 7, 8].

  4. 4

    If it is a borderline tumour or cancer

    A borderline tumour has a good outlook [9]. Read about the treatment of ovarian cancer and the chance of cure: Is ovarian cancer curable? and Ovarian cancer.

When should I contact a doctor?

Most ovarian cysts are harmless, but do not wait in these situations:

  • Sudden, severe pain in the pelvis or abdomen; the cyst may have twisted or burst [1, 4]. Go to an emergency department straight away or call your local emergency number.
  • Bloating, a growing abdomen, feeling full quickly, pelvic pain or needing to pass urine often that has started recently and happens on more than 12 days a month [10].
  • An ultrasound report with O-RADS 4 or 5, or a lump with an irregular solid part or fluid in the abdomen: see a gynaecologist soon [5, 6].
  • A cyst whose appearance has changed during follow-up, for example a new solid part or inner wall [3].

Frequently asked questions

What does O-RADS 4 mean? Does it mean I have cancer?

Not necessarily. O-RADS 4 means intermediate risk: out of 100 lumps with this score, 10 to fewer than 50 are cancerous; so most of these lumps are not cancer [6]. But this score needs further assessment with specialist ultrasound or MRI and the opinion of a gynaecological cancer surgeon [6, 7].

Is a complex ovarian cyst dangerous?

A "complex cyst" is a cyst that is not just clear fluid; for example, it has inner walls, blood, a solid part or small growths. Many of these cysts, such as haemorrhagic cysts, endometriomas ("chocolate cysts") or dermoid cysts, have a well-known appearance and are almost certainly benign [6]. The risk is decided by the type of these features, not by the word "complex"; this is why it is better for the ultrasound report to include an O-RADS score [5, 6].

Does the contraceptive pill make an ovarian cyst go away?

In eight studies of nearly 700 women, the contraceptive pill did not make functional cysts go away faster; most cysts went away without treatment within a few menstrual cycles [2]. Waiting 2 to 3 cycles and a repeat ultrasound is usually enough; a cyst that stays is usually not functional [2]. Read about the pill and cancer: Does the contraceptive pill cause cancer?

Is an ovarian cyst after the menopause dangerous?

A simple cyst after the menopause is also usually harmless: in a study of women aged 50 or over, no simple cyst smaller than 10 cm became cancer, and most went away on their own [3]. But age affects the decision [1], and a lump with a solid part needs a closer look after the menopause, as at any age [5, 6].

Is a borderline ovarian tumour cancer?

A borderline tumour has abnormal cells that may become cancer, but usually do not. Its outlook is good, especially when it is found early. At an early stage, women who want to have children can have only one ovary and fallopian tube, or part of an ovary, removed [9].

Does a high CA-125 mean my cyst is cancerous?

Not necessarily. CA-125 alone is not enough for a diagnosis, and the appearance of the cyst on ultrasound matters more [8]. Read: What does a high CA-125 mean?

If the cyst is cancerous, can it be treated?

The chance of curing ovarian cancer depends on its stage and type. Read: Is ovarian cancer curable?

For physicians

IOTA rules, O-RADS and the natural history of adnexal masses (for doctors)

For physiciansIOTA Simple Rules.
For physicians

IOTA Simple Rules. In 1066 patients with 1233 persistent adnexal masses (73% benign, 27% malignant), five M-rules (irregular solid tumour; ascites; at least 4 papillary structures; irregular multilocular-solid tumour with a largest diameter of 100 mm or more; very high colour content on colour Doppler) and five B-rules (unilocular cyst; solid components with a largest diameter of less than 7 mm; acoustic shadows; smooth multilocular tumour less than 100 mm; no detectable blood flow on Doppler) were defined. In prospective testing, the rules were applicable to 76% of masses (386 of 507), with a sensitivity of 95%, specificity of 91%, LR+‎ of 10.37 and LR−‎ of 0.06; for masses that cannot be classified by these rules, an expert ultrasound examiner is helpful [5].

O-RADS US. Six categories: 0 incomplete evaluation, 1 normal ovary, 2 almost certainly benign (<1%), 3 low risk (1% to <10%), 4 intermediate risk (10% to <50%) and 5 high risk (≥50%), with a management recommendation for each category and alignment with the IOTA ADNEX model [6]. Version 2022 added new benign features (bilocular cysts without solid components and acoustic shadowing in smooth-contoured solid lesions); because O-RADS 4 is an appropriate cut-off for malignancy, O-RADS 3 lesions are followed with ultrasound if not excised, and MRI is emphasised as a supplemental evaluation for solid lesions and cystic lesions with solid components [7].

ESGO/ISUOG/IOTA/ESGE (2021). Subjective assessment by an expert (Level III) ultrasound examiner performs best; when one is not available, the IOTA Simple Rules risk model or ADNEX model is recommended, as they outperform the RMI and other morphological scoring systems and are superior to CA-125, HE4 and ROMA. CA-125 is the best single-protein biomarker for pre-operative characterisation but is not useful for screening and does not improve the performance of ultrasound models; HE4 and ROMA do not improve on CA-125 alone; MRI with functional sequences is a second-line tool after ultrasound [8].

Natural history. IOTA5 (1919 patients with a new mass that looked benign on ultrasound, managed conservatively; median follow-up 27 months): 2-year cumulative incidence of spontaneous resolution 20.2%, invasive malignancy 0.4%, borderline tumour 0.3%, torsion 0.4% and cyst rupture 0.2% [4]. In the Kentucky screening programme (15,106 asymptomatic women aged 50 or over), 2763 women (18%) had 3259 unilocular cysts smaller than 10 cm; 69.4% resolved spontaneously, 16.5% developed a septum, 5.8% developed a solid area and 6.8% persisted as unilocular lesions; no woman with an isolated unilocular cyst developed ovarian cancer [3]. In a Cochrane review (8 trials, 686 women), combined oral contraceptives did not hasten the resolution of functional cysts; waiting 2 to 3 cycles is appropriate, and persistent cysts tend to be pathological (endometrioma or para-ovarian cyst) [2].

Goff symptom index. Pelvic or abdominal pain, urinary urgency or frequency, increased abdominal size or bloating, and difficulty eating or feeling full, present for less than 1 year and occurring more than 12 times a month; sensitivity 56.7% for early-stage and 79.5% for advanced-stage disease, and specificity 90% in women over 50 and 86.7% in women under 50 [10].

Scientific evidence

Scientific evidence

1 item
Other

Development of an ovarian cancer symptom index

Cancer · 2007
Pelvic/abdominal pain, urinary frequency/urgency, increased abdominal size/bloating, difficulty eating/feeling fullSymptoms associated with ovarian cancer (when present for less than 1 year and occurring more than 12 days a month)

Related cancer types

References

10 references
Show all references, 1 with a study cardClose the reference list

Numbers in the text, such as [1], refer to these sources. Sources with a “Study card” button are summarised in the site’s evidence library.

  1. 1
    Practice Bulletin No. 174: Evaluation and Management of Adnexal MassesObstet Gynecol · 2016;128:e210-e226
    DOIPubMed Back to text: 1 2 3 4 5 6 7 8 9
  2. 2
    Oral contraceptives for functional ovarian cystsGrimes DA, Jones LB, Lopez LM, et al · Cochrane Database Syst Rev · 2014;2014:CD006134
    DOIPubMed Back to text: 1 2 3 4 5 6 7 8 9 10 11
  3. 3
    Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameterModesitt SC, Pavlik EJ, Ueland FR, et al · Obstet Gynecol · 2003;102:594-9
    DOIPubMed Back to text: 1 2 3 4 5 6
  4. 4
    Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort studyFroyman W, Landolfo C, De Cock B, et al · Lancet Oncol · 2019;20:448-458
    DOIPubMed Back to text: 1 2 3 4 5
  5. 5
    Simple ultrasound-based rules for the diagnosis of ovarian cancerTimmerman D, Testa AC, Bourne T, et al · Ultrasound Obstet Gynecol · 2008;31:681-90
    DOIPubMed Back to text: 1 2 3 4 5 6 7 8
  6. 6
    O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System CommitteeAndreotti RF, Timmerman D, Strachowski LM, et al · Radiology · 2020;294:168-185
    DOIPubMed Back to text: 1 2 3 4 5 6 7 8 9 10 11 12 13
  7. 7
    O-RADS US v2022: An Update from the American College of Radiology's Ovarian-Adnexal Reporting and Data System US CommitteeStrachowski LM, Jha P, Phillips CH, et al · Radiology · 2023;308:e230685
    DOIPubMed Back to text: 1 2 3 4 5 6 7
  8. 8
    ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumorsTimmerman D, Planchamp F, Bourne T, et al · Int J Gynecol Cancer · 2021;31:961-982
    DOIPubMed Back to text: 1 2 3 4 5 6 7 8 9 10
  9. 9
    Ovarian Borderline Tumors Treatment (PDQ®)–Patient VersionNational Cancer Institute · cancer.gov · 2025
    Source Back to text: 1 2 3 4
  10. 10
    Development of an ovarian cancer symptom index: possibilities for earlier detectionGoff BA, Mandel LS, Drescher CW, et al · Cancer · 2007;109:221-7
    Study cardDOIPubMed Back to text: 1 2 3 4

This page is based on reputable scientific sources and was last updated on 28 October 2026. The content of this website is for educational and informational purposes only and does not replace consultation, diagnosis or treatment by a specialist physician. Consult your treating physician about any treatment decision.